RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Pranabananda Dutta to Heterochromatin

This is a "connection" page, showing publications Pranabananda Dutta has written about Heterochromatin.
Connection Strength

1.188
  1. Dutta P, Zhang L, Zhang H, Peng Q, Montgrain PR, Wang Y, Song Y, Li J, Li WX. Unphosphorylated STAT3 in heterochromatin formation and tumor suppression in lung cancer. BMC Cancer. 2020 Feb 22; 20(1):145.
    View in: PubMed
    Score: 0.721
  2. Loyola AC, Dao K, Shang R, Zhang L, Dutta P, Fowler C, Li J, Li WX. Streptonigrin at low concentration promotes heterochromatin formation. Sci Rep. 2020 02 26; 10(1):3478.
    View in: PubMed
    Score: 0.180
  3. Loyola AC, Zhang L, Shang R, Dutta P, Li J, Li WX. Identification of methotrexate as a heterochromatin-promoting drug. Sci Rep. 2019 08 12; 9(1):11673.
    View in: PubMed
    Score: 0.174
  4. Hu X, Dutta P, Tsurumi A, Li J, Wang J, Land H, Li WX. Unphosphorylated STAT5A stabilizes heterochromatin and suppresses tumor growth. Proc Natl Acad Sci U S A. 2013 Jun 18; 110(25):10213-8.
    View in: PubMed
    Score: 0.113
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support